|
Protectus Medical
Devides, Inc.
Protectus Medical
Devices, Inc. (formerly SquareOne Medical,
Inc.) has developed and patented innovative safety
medical percutaneous devices that, collectively,
have the potential to dramatically reduce
needlestick injuries for medical professionals
worldwide.

The product's status as the sole fully
automatic,self-sheathing
syringe gives Protectus Medical the
potential to gain a substantial share of the nearly
$5 Billion global hypodermic syringe market.
Protectus Medical
Devices has successfully patented its automatic
self-sheathing hypodermic safety syringe product,
and, based on the results of full comparison
clinical trials, the Protectus device has received
the required 510(k) permission from the U.S. FDA to
market and sell the device in the U.S.
The Protectus Safety Syringe was also designed with
clear manufacturing principles and assembly
logistics in mind allowing efficient and
cost-effective manufacture and automated assembly
that, in turn, allow the Company to offer this
long-awaited solution to the healthcare industry at
prices only modestly higher than conventional
syringes, while at the same time allowing
respectable margins for profitability.
The simple fact that there have been so many
different attempts to find the universal solution to
the safety syringe design is testimony (a) to its
high level of importance to the healthcare industry
and (b) that, until now, the solution had not been
found. The Protectus solution is the universal
solution and is tantamount to finding the Holy Grail
of percutaneous devices, not just for the safety
syringe application, but for other key applications,
as well.
News Headlines
-
Protectus Medical Devices,
Inc. Files for Patent Protection for Its Safety
Syringe in Taiwan: International Patent
Initiative Is Commenced
Marketwire(Thu, Oct 21)
-
Protectus Medical Devices,
Inc. CEO Begins Series of Interviews With
Shareholder Development Group, LLC
Marketwire(Tue, Oct 19)
-
Protectus Medical Devices
Receives U.S. Patent for Its Safety Syringe
Marketwire(Wed, Sep 22)
-
Protectus Medical Devices
CEO Addresses Development and Advantages of
Protectus Medical Safety Syringe
Marketwire(Mon, Sep 20)
-
Protectus CEO Updates
Shareholders on Current Quarter Events
Marketwire(Thu, Sep 16)
-
Protectus Medical CEO to
Attend Rodman & Renshaw Annual Global Healthcare
Conference Marketwire(Mon, Sep
13)
-
PROTECTUS MEDICAL DEVICES,
INC. Financials
EDGAR Online Financials(Fri, Aug 27)
-
PROTECTUS MEDICAL DEVICES,
INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online(Mon, Aug 23)
-
Protectus Medical Devices
Appoints as Medical Director a Physician Surgeon
With 20-Year Involvement in Senior Level
Monitoring of Pharmaceutical and Medical Devices
PR Newswire(Thu, Aug 19)
-
PROTECTUS MEDICAL DEVICES,
INC. Files SEC form 8-K, Changes in Registrant's
Certifying Accountant, Financial Statemen
EDGAR Online(Mon, Aug 2)
|
|
Company
Information
Protectus Medical
Devices, Inc.
110 First Avenue NE
Suite #1006
Minneapolis, MN 55413Company Officers
John Salstrom: President and CEO
John Olinger: CIO
Jack Dillard: VP of Operations, COO
Ronald Ginn: VP of Marketing & Sales, CMO
Stock Symbol: OTCQB (PTMD.PK)
Get Quote:
Click Here
Website:
http://www.protectusmedical.com |
 |